Filter News
Area of Research
- (-) Nuclear Science and Technology (12)
- Biology and Environment (11)
- Clean Energy (26)
- Climate and Environmental Systems (2)
- Computer Science (2)
- Fusion Energy (2)
- Isotopes (3)
- Materials (47)
- Materials for Computing (3)
- National Security (6)
- Neutron Science (13)
- Quantum information Science (1)
- Supercomputing (36)
News Type
News Topics
- (-) Computer Science (2)
- (-) Isotopes (5)
- (-) Materials Science (2)
- (-) Molten Salt (4)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (8)
- Bioenergy (1)
- Biomedical (2)
- Coronavirus (1)
- Cybersecurity (1)
- Decarbonization (1)
- Environment (1)
- Fusion (6)
- Neutron Science (4)
- Nuclear Energy (22)
- Physics (1)
- Space Exploration (2)
- Sustainable Energy (1)
- Transformational Challenge Reactor (3)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
Thanks in large part to developing and operating a facility for testing molten salt reactor (MSR) technologies, nuclear experts at the Energy Department’s Oak Ridge National Laboratory (ORNL) are now tackling the next generation of another type of clean energy—concentrating ...